全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Socioeconomic Factors Affect Disparities in Access to Liver Transplant for Hepatocellular Cancer

DOI: 10.1155/2012/870659

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective. The incidence/death rate of hepatocellular cancer (HCC) is increasing in America, and it is unclear if access to care contributes to this increase. Design/Patients. 575 HCC cases were reviewed for demographics, education, and tumor size. Main Outcome Measures. Endpoints to determine access to HCC care included whether an eligible patient underwent liver transplantation. Results. Transplant patients versus those not transplanted were younger (55.7 versus 61.8 yrs, ), males (89.3% versus 74.4%, ), and having completed high school (10.1% versus 1.2%, ). There were differences in transplant by ethnicity, insurance, and occupation. Transplant patients with HCC had higher median income via census classification ($54,383 versus $49,383, ) and self-reported income ($48,948 versus $38,800, ). Differences in access may be related to exclusion criteria for liver transplant, as Pacific Islanders were more likely to have tumor size larger than 5?cm compared to Whites and have BMI > 35 (20.7%) compared to Whites (6.4%) and Asians (4.7%). Conclusions. Ethnic differences in access to transplant are associated with socioeconomic status and factors that can disqualify patients (advanced disease/morbid obesity). Efforts to overcome educational barriers and screening for HCC could improve access to transplant. 1. Introduction Hepatocellular cancer is the fifth most common cancer worldwide and is the fifth leading cause of cancer death in males in the USA. Although cancer incidence in the USA is generally decreasing, HCC is one of a few cancers that is increasing in incidence and death rate [1, 2]. The best treatment for long-term disease-free survival with hepatocellular cancer is liver transplantation. Those who qualify for liver transplant must have localized disease, not amenable to surgical resection, and access to donor livers. Because of limited donor livers, criteria have been developed to transplant those patients with HCC who have the best prognosis. The recommended criteria include tumor characteristics—specifically Milan criteria with a single tumor less than 5?cm or 3 tumors all less than 3?cm and without evidence of vascular invasion or extrahepatic spread of tumor [3, 4]. There are also other criteria for liver transplant that relate to the presence of other medical comorbidities, psychosocial factors, and the ability to finance the transplant procedure. Some of the latter criteria vary from center to center, but all centers aim to transplant those patients who are a reasonable operative risk and who demonstrate adequate compliance, psychosocial

References

[1]  SEER Cancer Statistics Review 1975–2004, “US National Institute of Health,” 2012, http://www.SEER.cancer.gov.
[2]  R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics 2012,” CA: A Cancer Journal for Clinicians, vol. 62, pp. 10–31, 2012.
[3]  V. Mazzaferro, E. Regalia, R. Doci et al., “Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis,” New England Journal of Medicine, vol. 334, no. 11, pp. 693–699, 1996.
[4]  J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011.
[5]  S. F. Altekruse, K. A. McGlynn, L. A. Dickie, and D. E. Kleiner, “Hepatocellular carcinoma confirmation, treatment and survival in surveillance, epidemiology and end results registries 1992–2008,” Hepatology, vol. 55, pp. 476–482, 2012.
[6]  A. K. Mathur, D. E. Schaubel, Q. Gong, M. K. Guidinger, and R. M. Merion, “Sex-based disparities in liver transplant rates in the United States,” American Journal of Transplantation, vol. 11, no. 7, pp. 1435–1443, 2011.
[7]  A. S. Robbins, D. D. Cox, L. B. Johnson, and E. M. Ward, “Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007,” Cancer, vol. 117, pp. 4531–4539, 2011.
[8]  Z. Kadry, W. E. Schaefer, T. Uemura, A. R. Shah, I. Schreibman, and T. R. Rile, “Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States,” Journal of Hepatology, vol. 56, pp. 618–625, 2012.
[9]  J. C. Yu, A. I. Neugut, S. Wang et al., “Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma,” Cancer, vol. 116, no. 7, pp. 1801–1809, 2010.
[10]  A. Artinyan, B. Mailey, N. Sanchez-Luege et al., “Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States,” Cancer, vol. 116, no. 5, pp. 1367–1377, 2010.
[11]  United Network for Organ Sharing , Policy 3.6: Organ Distrubution: Allocation of Livers, 2012, http://optn.transplant.hrsa.gov/policiesAndBylaws/.
[12]  US census data 2011, State of Hawaii, 2012, http://quickfacts.census.gov/qfd/index.html.
[13]  ZipWho for Median household income, 2012, http://zipwho.com/.
[14]  S. Baum, J. Ma, and K. Payza, “Education Pays 2010,” Trends in Higher Education series, College Board Advocacy and Policy Center, 2010, http://trends.collegeboard.org/sites/default/files/education-pays-2010-full-report.PDF.
[15]  A. K. Mathur, D. E. Schaubel, Q. Gong, M. K. Guidinger, and R. M. Merion, “Racial and ethnic disparities in access to liver transplantation,” Liver Transplantation, vol. 16, no. 9, pp. 1033–1040, 2010.
[16]  A. K. Mathur, C. J. Sonnenday, and R. M. Merion, “Race and ethnicity in access to and outcomes of liver transplantation: a critical literature review,” American Journal of Transplantation, vol. 9, no. 12, pp. 2662–2668, 2009.
[17]  H. L. Tae, N. Shah, R. A. Pedersen et al., “Survival after liver transplantation: is racial disparity inevitable?” Hepatology, vol. 46, no. 5, pp. 1491–1497, 2007.
[18]  D. E. Eckhoff, B. M. McGuire, C. J. Young et al., “Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation?” Liver Transplantation and Surgery, vol. 4, no. 6, pp. 499–505, 1998.
[19]  V. R. Julapalli, J. R. Kramer, and H. B. El-Serag, “Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center,” Liver Transplantation, vol. 11, no. 11, pp. 1370–1378, 2005.
[20]  G. C. Nguyen, D. L. Segev, and P. J. Thuluvath, “Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study,” Hepatology, vol. 45, no. 5, pp. 1282–1289, 2007.
[21]  P. A. McCormick, M. O'Rourke, D. Carey, and M. Laffoy, “Ability to pay and geographical proximity influence access to liver transplantation even in a system with universal access,” Liver Transplantation, vol. 10, no. 11, pp. 1422–1427, 2004.
[22]  J. E. Tuttle-Newhall, R. Rutledge, M. Johnson, and J. Fair, “A statewide, population-based, time series analysis of access to liver transplantation,” Transplantation, vol. 63, no. 2, pp. 255–262, 1997.
[23]  Y. Zak, K. F. Rhoads, and B. C. Visser, “Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type,” Archives of Surgery, vol. 146, no. 7, pp. 778–784, 2011.
[24]  A. K. Mathur, N. H. Osborne, R. J. Lynch, A. A. Ghaferi, J. B. Dimick, and C. J. Sonnenday, “Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma,” Archives of Surgery, vol. 145, no. 12, pp. 1158–1163, 2010.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133